B. Riley Wealth Advisors Inc. lowered its stake in Xylem Inc. (NYSE:XYL – Free Report) by 12.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,786 shares of the industrial products company’s stock after selling 1,083 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Xylem were worth $890,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in XYL. Norges Bank purchased a new stake in Xylem in the fourth quarter worth approximately $198,207,000. Artisan Partners Limited Partnership purchased a new position in shares of Xylem during the 4th quarter worth $187,207,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its stake in shares of Xylem by 1,503.7% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,649,926 shares of the industrial products company’s stock worth $188,685,000 after acquiring an additional 1,547,043 shares during the last quarter. Kodai Capital Management LP purchased a new position in shares of Xylem during the 4th quarter worth $133,945,000. Finally, Balyasny Asset Management L.P. boosted its stake in shares of Xylem by 4,769.0% during the 4th quarter. Balyasny Asset Management L.P. now owns 927,390 shares of the industrial products company’s stock worth $106,056,000 after acquiring an additional 908,343 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Stock Down 0.8 %
Shares of XYL stock opened at $139.27 on Friday. The stock has a market cap of $33.77 billion, a P/E ratio of 49.56, a PEG ratio of 2.48 and a beta of 1.07. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $146.08. The company has a quick ratio of 1.22, a current ratio of 1.67 and a debt-to-equity ratio of 0.19. The company’s fifty day simple moving average is $137.58 and its two-hundred day simple moving average is $125.60.
Xylem Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 27th. Shareholders of record on Thursday, May 30th will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 1.03%. The ex-dividend date is Thursday, May 30th. Xylem’s payout ratio is currently 51.25%.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on the stock. BNP Paribas assumed coverage on shares of Xylem in a research note on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price target on the stock. Oppenheimer lifted their price target on shares of Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Mizuho lifted their price target on shares of Xylem from $110.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, May 3rd. TD Cowen lifted their price target on shares of Xylem from $135.00 to $138.00 and gave the stock a “buy” rating in a research note on Thursday, June 6th. Finally, Argus lifted their target price on shares of Xylem from $146.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 29th. Five equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $142.92.
Read Our Latest Stock Analysis on Xylem
Insiders Place Their Bets
In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the sale, the chief accounting officer now owns 3,536 shares in the company, valued at approximately $490,195.68. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CAO Geri-Michelle Mcshane sold 2,278 shares of the company’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the sale, the chief accounting officer now directly owns 3,536 shares in the company, valued at approximately $490,195.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Rodney Aulick sold 21,800 shares of the company’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the sale, the senior vice president now owns 76,287 shares in the company, valued at $10,604,655.87. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More
- Five stocks we like better than Xylem
- How to Use the MarketBeat Excel Dividend Calculator
- Darden Stock Up After Q4 Earnings Beat, Cautious FY25 Outlook
- What is a Stock Market Index and How Do You Use Them?
- Celsius Stock: Why Piper Sandler Forecasts a 50% Surge
- Stock Market Sectors: What Are They and How Many Are There?
- Accenture’s Stock Earnings Reveal an AI-Powered Growth Strategy
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.